71% LOWER BREAST CANCER RISK With Vitamin D Level of 60 vs. 20 ng/ml 

~85% LOWER BREAST CANCER RISK With Vitamin D Level of 85 vs. 20 ng/ml [estimate from this chart]

~92% LOWER BREAST CANCER RISK With Vitamin D Level of 95 vs. 20 ng/ml [estimate from this chart]

30-100 ng/ml blood level is considered “normal.” Majority of Alaskans are at about 20 ng/ml — very high risk

10,000 iu of vitamin D3 per day will get many people to 80-100 ng/ml. Overweight and obese will likely require higher amounts to achieve 80-100 ng/ml

• To find out your level, Alaska Health Fair does vitamin D screenings for $50

– –

Analysis of 70 Studies Finds 71% Lower Breast Cancer Risk With Vitamin D Level of 60 vs. 20 ng/ml

October 27, 2020

Breast Cancer Risk ~70% Lower with Higher Vitamin D (60+ ng/ml) – Part 5

In a previous post we summarized an analysis published by GrassrootsHealth that showed women with vitamin D levels at or above 60 ng/ml (150 nmol/L) had an 80% lower breast cancer risk compared to women with levels less than 20 ng/ml (50 nmol/L). In another post we discussed a study that found the same result among women in the United Kingdom — an 83% lower breast cancer risk with vitamin D levels above 60 ng/ml. In today’s blog we will summarize the findings from a third study, a 2019 meta-analysis by Song et al. which analyzed data from 70 observational studies.

Breast Cancer Risk Declined as Vitamin D Level Rose

The dose response relationship between vitamin D level and breast cancer risk is shown on the chart below. Specifically, the researchers found a 6% decrease in breast cancer risk for every 2 ng/ml (5 nmol/L) increase in vitamin D level. This translates to a 71% lower risk from 20 to 60 ng/ml (50 to 150 nmol/L).

Click to Enlarge & Print

The similar findings between these three studies (GrassrootsHealth, Lowe et al., and Song et al.) emphasize the importance of improving vitamin D status for breast cancer prevention.

Entire Article

Entire study at PubMed:

Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies, 2019 Dec 28 — Song, et. al.